"Difficult Quarter": HIMS Plunges On Weak GLP-1 Sales

"Difficult Quarter": HIMS Plunges On Weak GLP-1 Sales Hims & Hers Health (HIMS), the telehealth platform known for selling compounded GLP-1 weight-loss drugs, tumbled in premarket trading in New York after missing Wall Street's revenue estimates in its Monday after-hours earnings release,…